Forbes J A, Sandberg R A, Bood-Björklund L
Forbes Group, Inc., Shrewsbury, Pennsylvania, USA.
Pharmacotherapy. 1998 May-Jun;18(3):492-503.
To evaluate the effect of a standard meal on bioavailability of bromfenac, and on the relative analgesic efficacy and adverse effect liability of bromfenac 25 mg, naproxen sodium 550 mg, and acetaminophen 325 mg in the treatment of pain after orthopedic surgery.
Randomized, double-blind, single-dose, parallel-group.
Two wards of the orthopedic surgery department at the Central Hospital, Karlstad, Sweden.
Three hundred ten patients with steady, moderate, or severe pain within 72 hours after orthopedic surgery.
Patients were randomly assigned both to receive a standard meal or remain in a fasted state, and to treatment with a single oral dose of bromfenac 25 mg, naproxen sodium 550 mg, or acetaminophen 325 mg, when they experienced steady, moderate, or severe pain that required an analgesic. Using a self-rating record, subjects rated their pain and its relief for up to 8 hours after medicating. Blood samples were obtained from all patients using one of two schedules.
The peak plasma bromfenac concentration for fed patients was only 28% of that of fasted patients. Disregarding food intake, bromfenac 25 mg and naproxen sodium 550 mg were significantly superior to acetaminophen 325 mg for all summary measures of analgesia. Bromfenac and naproxen were superior to acetaminophen by hour 1 and this difference persisted for 8 hours. Food reduced bromfenac's analgesic effect, but not that of naproxen or acetaminophen; treatment by meal interaction was significant for five measures of efficacy. Analgesic response for fed bromfenac recipients, compared with those who were fasted, ranged from 37-71%. The percentage of patients reporting an adverse effect was significantly higher for bromfenac (25%) and naproxen (24%) than for acetaminophen (12%).
Results of analgesic studies not taking patients' food status into consideration might be misleading. Although bromfenac 25 mg and naproxen sodium 550 mg produced significant analgesia compared with acetaminophen 325 mg, bromfenac's efficacy was significantly reduced when patients ate a standard meal. Adverse effects were transient and consistent with the pharmacologic profiles of the drugs.
评估标准餐对溴芬酸生物利用度的影响,以及评估溴芬酸25毫克、萘普生钠550毫克和对乙酰氨基酚325毫克在治疗骨科手术后疼痛时的相对镇痛效果和不良反应发生率。
随机、双盲、单剂量、平行组。
瑞典卡尔斯塔德中央医院骨科手术科的两个病房。
310例骨科手术后72小时内有稳定的中度或重度疼痛的患者。
患者被随机分配接受标准餐或保持禁食状态,并在经历稳定的中度或重度疼痛需要镇痛时,口服单剂量的溴芬酸25毫克、萘普生钠550毫克或对乙酰氨基酚325毫克进行治疗。使用自评记录,受试者在用药后长达8小时内对疼痛及其缓解情况进行评分。按照两种方案之一从所有患者身上采集血样。
进食患者的溴芬酸血浆峰值浓度仅为禁食患者的28%。不考虑食物摄入情况,在所有镇痛汇总指标方面,溴芬酸25毫克和萘普生钠550毫克均显著优于对乙酰氨基酚325毫克。溴芬酸和萘普生在1小时时就优于对乙酰氨基酚,且这种差异持续了8小时。食物降低了溴芬酸的镇痛效果,但未降低萘普生或对乙酰氨基酚的镇痛效果;进餐与治疗的相互作用对五项疗效指标有显著影响。与禁食的溴芬酸接受者相比,进食的溴芬酸接受者的镇痛反应范围为37%-71%。报告有不良反应的患者百分比,溴芬酸组(25%)和萘普生组(24%)显著高于对乙酰氨基酚组(12%)。
未考虑患者饮食状态的镇痛研究结果可能会产生误导。虽然与对乙酰氨基酚325毫克相比,溴芬酸25毫克和萘普生钠550毫克产生了显著的镇痛效果,但当患者进食标准餐时,溴芬酸的疗效显著降低。不良反应是短暂的,且与药物的药理特性一致。